Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 832-827-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08 April 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- OECD Guidelines for the Testing of Chemicals No. 438 (2018)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)
- Version / remarks:
- Commission Regulation (EU) 2017/735 of 14 February 2017 amending, the Annex to Regulation (EC) No 440/2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Oligomerisation products of alpha-alkenes C16-18 (even numbered), hydrogenated, hydroisomerised
- EC Number:
- 832-827-5
- Cas Number:
- 2241366-04-9
- Molecular formula:
- Variable - UVCB
- IUPAC Name:
- Oligomerisation products of alpha-alkenes C16-18 (even numbered), hydrogenated, hydroisomerised
- Test material form:
- liquid
- Details on test material:
- Name: SynNova Base Oil
CAS number: 2241366-04-9
Batch/Lot number: TS20371/TS21270
Description: Liquid - water white colorless oil.
Purity: 100%
Expiry date: 25 February 2021/31 July 2021
Storage conditions: Controlled room temperature (15-25°C, ≤70% relative humidity)
Safety precautions: Routine safety precautions (gloves, goggles, face mask, lab coat) for unknown materials were applied to ensure personnel health and safety.
Constituent 1
- Specific details on test material used for the study:
- No further details specified in the study report.
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: ROSS 308
- Details on test animals or tissues and environmental conditions:
- Strain of chicken: ROSS 308
Source: TARAVIS KFT. (Address: 9600 Sárvár, Rábasömjéni út 129., Hungary)
Chicken heads were collected after slaughter in a commercial abattoir from chickens (approximately 7 weeks old) which are used for human consumption. Heads were collected by a slaughter house technician and heads transported to Citoxlab Hungary Ltd. at ambient temperature at the earliest convenience.
After collection, the heads were inspected for appropriate quality and wrapped with tissue paper moistened with saline, then placed in a plastic box which was closed (4-5 heads per box). The heads were received at Citoxlab Hungary Ltd. and processed within 2 hours of collection.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 30 μL of the test item was applied onto the entire surface of the cornea.
One negative control eye was treated with 30 μL of physiological saline
Three positive control eyes were treated with 30 μL 5% (w/v) Benzalkonium chloride solution. - Duration of treatment / exposure:
- exposure period of 10 seconds from the end of the application
- Duration of post- treatment incubation (in vitro):
- The control eyes and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse.
- Number of animals or in vitro replicates:
- 7 replicates (3 test item/3 positive control/ 1 negative control)
- Details on study design:
- SELECTION AND PREPARATION OF EYES FOR THE TEST
Eyes selection
After removing the head from the plastic box, it was put on soft paper. The eyelids were carefully cut away with scissors, avoiding damaging the cornea. One small drop of 2% (w/v) fluorescein solution was applied onto the cornea surface for a few seconds and subsequently rinsed off with 20 mL physiological saline. Then the fluorescein-treated cornea was examined with a hand-held slit lamp or slit lamp microscope, with the eye in the head, to ensure that the cornea was not damaged. If the cornea was in good condition, the eyeball was carefully removed from the orbit.
Preparation of eyes
The eye ball was carefully removed from the orbit by holding the nictitating membrane with a surgical forceps, while cutting the eye muscles with bent scissors. Care was taken to remove the eyeball from the orbit without cutting off the optical nerve too short. The procedure avoided pressure on the eye while removing the eyeball from the orbit, in order to prevent distortion of the cornea and subsequent corneal opacity. Once removed from the orbit, the eye was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eyes were kept on the wet papers in a closed box so that the appropriate humidity was maintained.
Eyes examination and acclimatization time
The prepared eye was placed in a steel clamp with the cornea positioned vertically with the eye in the correct relative position (same position as in the chicken head). Again avoiding too much pressure on the eye by the clamp. Because of the relatively firm sclera of the chicken eyeball, only slight pressure was needed to fix the eye properly. The clamp with the eyeball was transferred to a chamber of the superfusion apparatus. The clamp holding the eye was positioned in such a way that the entire cornea was supplied with physiological saline solution dripping from a stainless steel tube, at a rate of approximately 3-4 drops/minute or 0.1 to 0.15 mL/minutes. The door of the chamber was closed except for manipulations and examinations, to maintain temperature and humidity.
The appropriate number of eyes was selected and were placed in the superfusion apparatus. There they were examined again with the slit lamp microscope to ensure that they were in good condition. The focus was adjusted to see clearly the physiological saline which was flowing on the cornea surface. Eyes with a high baseline fluorescein staining (i.e., > 0.5) or corneal opacity score (i.e., > 0.5) were rejected. The cornea thickness was measured, any eye with cornea thickness deviating more than 10 % from the mean value for all eyes, or eyes that showed any other signs of damage, were rejected and replaced. If the selected eyes were appropriate for the test, acclimatization started and it was conducted for approximately 45 to 60 minutes. The chambers of the superfusion apparatus were at controlled temperature (32±1.5°C) during the acclimatization and treatment periods.
Identification
The eyes were identified by chamber number, marked on the door of the chamber.
THE BASELINE ASSESSMENTS
At the end of the acclimatization period, a zero reference measurement was recorded for cornea thickness and opacity to serve as a baseline (t=0) for each individual eye. The cornea thickness of the eyes should not change during acclimatization by more than 5% between the -45 minute and the zero time. No changes in thickness (0.0%) were observed in the eyes used in the study. Following the equilibration period, the fluorescein retention was measured. Baseline values were required to evaluate any potential test item related effect after treatment. All eyes were considered to be suitable for the assay.
TEST PROCEDURE
Treatment
After the zero reference measurements, the eye in its retainer was taken out of the chamber and placed on a layer of tissue with the cornea facing upwards. The eye was held in horizontal position, while the test material was applied onto the centre of the cornea. In the study, 30 μL of the test item was applied onto the entire surface of the cornea attempting to cover the cornea surface uniformly with the test item, taking care not to damage or touch the cornea. Three test item treated eyes were examined in the study.
One negative control eye was treated with 30 μL of physiological saline; three positive control eyes were treated with 30 μL 5% (w/v) Benzalkonium chloride solution.
Test item removal
The time of application was observed, then after an exposure period of 10 seconds from the end of the application, the cornea surface was rinsed thoroughly with 20 mL physiological saline* at ambient temperature, taking care not to damage the cornea but attempting to remove all residual of the test item if possible.
*Note: Physiological saline (Manufacturer: B. Braun Pharmaceuticals SA, Lot number: 84222Y05-1, Expiry date: 30 September 2021) was used for rinsing.
OBSERVATION
Observation and assessment of corneal effects
The control eyes and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within approximately ±5 minutes were considered acceptable.
Corneal thickness and corneal opacity were measured at all time points. Fluorescein retention was measured on two occasions, at baseline (t=0) and approximately 30 minutes after the post-treatment rinse. Haag-Streit BP 900® slit-lamp microscope was used for the measurements.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- up to 75 min - Test item
- Value:
- 0.6
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- up to 240 min - Test item
- Value:
- 1.7
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- MORPHOLOGICAL EFFECTS
Severe loosening of epithelium was observed on one eye at 120 minutes and on one eye at 180 minutes after the post-treatment rinse in case of the positive control material.
VALIDITY OF THE TEST
The results from all eyes used met the quality control standards. The negative control and positive control results were within the historical data range in the experiment. This study was considered to be valid.
Any other information on results incl. tables
TEST ITEM
Observation |
Value |
ICE Class |
Mean maximum corneal swelling up to 75 min |
0.6% |
I |
Mean maximum corneal swelling up to 240 min |
1.7% |
I |
Mean maximum corneal opacity change |
0.00 |
I |
Mean fluorescein retention change |
0.33 |
I |
Other Observations |
None |
|
Overall ICE Class |
3xI |
Based on this in vitro eye irritation assay in isolated chicken eyes with SynNova Base Oil, the test item is non-irritant, UN GHS Classification: No Category
POSITIVE CONTROL
Observation |
Value |
ICE Class |
Mean maximum corneal swelling up to 75 min |
11.5% |
II |
Mean maximum corneal swelling up to 240 min |
28.4% |
III |
Mean maximum corneal opacity change |
4.00 |
IV |
Mean fluorescein retention change |
3.00 |
IV |
Other Observations |
Severe loosening of epithelium was observed on one eye at 120 minutes and on one eye at 180 minutes after post-treatment rinse. |
|
Overall ICE Class |
1xIII 2xIV |
The positive control (5% (w/v) Benzalkonium chloride solution) was classified as severely irritating, UN GHS Classification: Category 1.
NEGATIVE CONTROL
Observation |
Value |
ICE Class |
Mean maximum corneal swelling up to 75 min |
0.0% |
I |
Mean maximum corneal swelling up to 240 min |
0.0% |
I |
Mean maximum corneal opacity change |
0.00 |
I |
Mean fluorescein retention change |
0.00 |
I |
Other Observations |
None |
|
Overall ICE Class |
3xI |
The negative control Physiological saline was classified as non-irritating, UN GHS Classification: No Category.
SUMMARY TABLE FOR UN GHS CLASSIFICATION
Criteria for “No category” (all true) |
|
3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II, or 2 endpoints classed as II and 1 endpoint classed as I: |
True |
No severe corneal morphological changes: |
True |
Test item was not stuck to the cornea at 240 minutes after the post-treatment rinse: |
True |
Criteria for “Category 1” (one or more true) |
|
2 or more endpoints classed as IV: |
False |
Corneal opacity = 3 at 30 min (in at least 2 eyes): |
False |
Corneal opacity = 4 at any time point (in at least 2 eyes): |
False |
Severe loosening of epithelium (in at least 1 eye): |
False |
Criteria for “No prediction can be made” (one or two true) |
|
Based on the endpoints not classifiable for No Category, or for Category 1: |
False |
Particles of test item were stuck to the cornea and could not be washed off during the study: |
False |
Historical Control Data (updated on 07 November 2018):
Negative Control: Physiological Saline
Observation |
Min. Value |
Max. Value |
Maximum corneal swelling at up to 75 min |
-3.2% |
3.4% |
Maximum corneal swelling at up to 240 min |
-4.8% |
3.4% |
Maximum corneal opacity change |
0.00 |
0.50 |
Fluorescein retention |
0.00 |
0.50 |
Number of cases |
416 |
Positive Control: 5% (w/v) Benzalkonium chloride solution
Observation |
Min. Value |
Max. Value |
Maximum corneal swelling at up to 75 min |
-8.5% |
27.0% |
Maximum corneal swelling at up to 240 min |
-10.7% |
38.3% |
Maximum corneal opacity change |
2.50 |
4.00 |
Fluorescein retention |
1.50 |
3.00 |
Number of cases |
234 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on this in vitro eye irritation assay in isolated chicken eyes with SynNova Base Oil, the test item is non-irritant, UN GHS Classification: No Category.
- Executive summary:
An in vitro eye irritation study of the test item was performed in isolated chicken’s eyes. The irritation effects of the test item were evaluated according to the OECD No. 438 (25 June 2018).
After the zero time reference measurements, the eyes were held in horizontal position and 30 μL of the test item was applied onto the centre of the corneas such that the entire surface of the corneas were covered. After 10 seconds, the surface was rinsed with physiological saline. The positive control eyes were treated with 30 μL of 5% (w/v) Benzalkonium chloride solution. The negative control eye was treated with 30 μL of physiological saline (0.9% (w/v) NaCl solution). In the study, three treated eyes per test item, three positive control treated eyes and one negative control treated eye were examined.
The results from all eyes used in the study met the quality control standards. The negative control and positive control results were in good correlation with the historical control data. Thus, the experiment was considered to be valid.
No significant corneal swelling (mean <5.0%) was observed during the four-hour observation period on the test item treated eyes. No corneal opacity change (severity 0.0) was noted on all eyes. No significant fluorescein retention change (severity 0.0 on one eye and severity 0.5 on two eyes) was noted on all eyes. No other corneal effects were observed.
Based on this in vitro eye irritation assay in isolated chicken eyes with SynNova Base Oil, the test item is non-irritant, UN GHS Classification: No Category.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.